Department of Molecular and Cellular Oncology articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/09/29 07:17
2014/09/29 07:17
23d
Transgene SA (NYSE-Euronext: TNG)(Paris:TNG) today announced the presentation1 of more mature data from the Phase 2b part of the TIME trial with TG4010 MUC1 targeted immunotherapy at the European...
2014/09/29 07:17
2014/09/29 07:17
Latest videos
2014/09/29 07:17
2014/09/29 07:17
Latest from Twitter